EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -3.500
March 31, 2026 -3.400
December 31, 2025 -3.315
September 30, 2025 -3.213
June 30, 2025 -3.346
March 31, 2025 -3.379
December 31, 2024 -3.556
September 30, 2024 -4.237
June 30, 2024 -4.092
March 31, 2024 -3.923
December 31, 2023 -4.279
September 30, 2023 -4.066
June 30, 2023 -4.918
March 31, 2023 -6.498
December 31, 2022 -6.407
September 30, 2022 -5.936
June 30, 2022 -5.412
March 31, 2022 -4.128
December 31, 2021 -4.005
Date Value
September 30, 2021 -4.048
June 30, 2021 -3.768
March 31, 2021 -3.373
December 31, 2020 -2.580
September 30, 2020 -1.911
June 30, 2020 -1.268
March 31, 2020 -0.8294
December 31, 2019 -0.8387
September 30, 2019 -0.8691
June 30, 2019 -1.017
March 31, 2019 -1.140
December 31, 2018 -0.9991
September 30, 2018 -0.8768
June 30, 2018 -0.9262
March 31, 2018 -0.9486
December 31, 2017 -0.9741
September 30, 2017 -0.7978
June 30, 2017 -0.4632
March 31, 2017 -0.1875

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Natera, Inc. -1.368
NeoGenomics, Inc. -0.4034
Quest Diagnostics, Inc. 9.427
Labcorp Holdings, Inc. 12.09
OPKO Health, Inc. -0.0965